Russian Spútnik V vaccine should be passed this week for use in the EU

The European Medicines Agency (EMA) are due to travel to Moscow this week to review clinical trials of the world's first patented vaccine, Russia's Spútnik, with view to certifying for use in the European Union, making it the fifth vaccine to be available for use.

The EMA has not officially announced their visit, but the Russian Minister of Health, Mikhail Murashko, has done so, saying that they are arriving in Moscow on Saturday, April 10^th, adding that this trip should be the final phase for the European regulator to include the Russian vaccine among those authorized in the EU. He further claims that Spútnik could be the best solution to accelerate immunization in Europe.